Bone in osteogenesis imperfecta: features and therapy
Frontiers in Cell and Developmental Biology · 29.10.2026 · 14
DOI: 10.3389/fcell.2026.1950969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 29.10.2026. Verfasst von Giacomina Brunetti. Beteiligte Einrichtung: Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Bari, Italy. Die Arbeit nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteogenesis imperfecta (OI) is a heterogeneous group of inherited bone dysplasia, characterized by low bone mass and bone fragility with possible development of fractures. OI has been known as a predominantly inherited disease caused by mutations in either of the genes encoding type I collagen ( COL1A1 and COL1A2 ). Further studies in recent years have identified new mutations in collagen-related genes, leading to the identification and classification of different types of OI. Therapeutic approaches have concentrated on the use of bisphosphonates and/or monoclonal antibodies as elective therapy, but different trials are ongoing using cell and gene therapies, and these offer new options for OI patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Bari, Italy.
Zitieren
APA
Brunetti, G. (2026). Bone in osteogenesis imperfecta: features and therapy. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1950969
Vancouver
Brunetti G. Bone in osteogenesis imperfecta: features and therapy. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1950969
BibTeX
@article{Brunetti2026,
author = {Brunetti, Giacomina},
title = {Bone in osteogenesis imperfecta: features and therapy},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1950969}
}
EUVIMED